validated

• Health

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

Targets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules, monoclonal antibodies,…